Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metabotropic glutamate receptor 7 (mGluR7) is a G protein-coupled receptor (GPCR) encoded by the GRM7 gene in humans. It belongs to the group III metabotropic glutamate receptors. mGluR7 is highly expressed throughout the central nervous system (CNS), especially at presynaptic active zones of both excitatory (glutamatergic) and inhibitory (GABAergic) neurons. It functions as both an auto-receptor on glutamatergic terminals and a hetero-receptor on GABAergic terminals, modulating neurotransmitter release. mGluR7 is activated by L-glutamate but has much lower affinity compared to other metabotropic glutamate receptors. It couples primarily to Gi/o proteins upon activation and is implicated in several CNS disorders. Selective agonists/antagonists/allosteric modulators are under investigation as potential therapies targeting these conditions.
Gi/o-coupled; inhibits cAMP production, opens GIRK potassium channels, inhibits voltage-gated calcium channels
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metabotropic Glutamate Receptor 7 (mGluR7).